Results:

1. Nagata et al (2016) The effectiveness of Lactobacillus beverage in controlling infections among the residents of an aged care facility: a randomized placebo-controlled double-blind trial.

2. Motoori et al (2015) Randomized study of the effect of synbiotics during neoadjuvant chemotherapy on adverse events in esophageal cancer patients.

3. Wang C et al (2015) Intestinal microbiota profiles of healthy pre-school and school-age children and effects of probiotic supplementation

4. Wang R et al (2015) Survival of Lactobacillus casei strain Shirota in the intestines of healthy Chinese adults

5. Okubo H et al (2013) Lactobacillus casei Shirota protects against non-alcoholic steatohepatitis development in a rat model.

6. Mendonça FHBP et al (2013) Effects of probiotic bacteria on Candida presence and IgA anti-Candida in the oral cavity of elderly

7. Hayakawa M et al (2012) Synbiotic therapy reduces the pathological Gram-negative rods caused by an increased acetic acid concentration in the gut

8. You & Yaqoob (2012) Evidence of immunomodulatory effects of a novel probiotic, Bifidobacterium longum bv. infantis CCUG 524866

9. Bian et al (2011) Effects of the continuous intake of Lactobacillus casei strain Shirota-fermented milk on risk management of long-term inpatients at health service facilities for the elderly

10. Spanhaak et al(1998) The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans

11. Ohashi et al (2001) Lactobacillus casei strain Shirota-fermented milk stimulates indigenous lactobacilli in the pig intestine.

12. Kanamori et al (2001) Combination therapy with Bifidobacterium breve, Lactobacillus casei, and galactooligosaccharides dramatically improved the intestinal function in a girl with short bowel syndrome: a novel synbiotics therapy for intestinal failure

13. Sugawara et al (2006) Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: A randomized controlled trial

14. Shioiri et al (2006) The effects of a synbiotic fermented milk beverage containing Lactobacillus casei strain Shirota and transgalactosylated oligosaccharides on defecation frequency, intestinal microflora, organic acid concentrations, and putrefactive metabolites of sub-optimal health state volunteers: a randomized placebo-controlled cross-over study

15. Matsumoto et al (2006) The effect of a probiotic milk product containing Lactobacillus casei strain Shirota on the defecation frequency and the intestinal microflora of sub-optimal health state volunteers: a randomized placebo-controlled cross-over study

16. Tuohy et al (2007) Survivability of a probiotic Lactobacillus casei in the gastrointestinal tract of healthy human volunteers and its impact on the faecal microflora.

17. Shimizu et al (2009) Synbiotics decrease the incidence of septic complications in patients with severe SIRS: A preliminary report

18. Rao et al (2009) A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome

19. Usami et al (2011) Effects of perioperative synbiotic treatment on infectious complications, intestinal integrity and faecal flora and organic acids in hepatic surgery with or without cirrhosis

20. Nagata et al (2011) Effect of the continuous intake of probiotic-fermented milk containing Lactobacillus casei strain Shirota on fever in a mass outbreak of norovirus gastroenteritis and the faecal microflora in a health service facility for the aged